상세 보기
자료 필터
자료유형
발행연도
2008 ~ 2025
2008 2025
키워드
언어
선택된 필터
- article
- conference
- book
전체 122건 중 1번부터 10번까지의 결과를 표시합니다.
2025
Article
Efficacy and Safety of Herbal Medicine Bojungikki-Tang in Combination with Pembrolizumab versus Pembrolizumab Monotherapy for Stage IV Non-Small Cell Lung Cancer: Study Protocol for a Randomized, Open-Label, Double-Arm, Multicenter Trial
- Cho, Eunbyul ;
- Yi, Jin-Mu ;
- Chun, Jaemoo ;
- Jang, Ho ;
- Yoon, Seong Hoon ;
- ... Lee, Sung Yong ;
- 외 6명
- 2025
- Integrative Cancer Therapies
- SAGE PUBLICATIONS INC
2024
Article
Rapid Progression of Acute Interstitial Pneumonia in a Patient with Low MDA-5 Antibody Titer
- Chang, Sung Won ;
- Min, Kyung Hoon ;
- Lee, Sung Yong ;
- Shim, Jae Jeong ;
- Hur, Gyu-Young
- 2024-07-04
- American Journal of Case Reports
- International Scientific Information, Inc.
Article
Nanoplasmonic Detection of EGFR Mutations Based on Extracellular Vesicle-Derived EGFR-Drug Interaction
- Han, Junhee ;
- Jung, Jik-Han ;
- Lee, Sung Yong ;
- Park, Ji-Ho
- 2024-02-09
- ACS Applied Materials & Interfaces
- AMER CHEMICAL SOC
Article
The Real-World Outcome of First Line Atezolizumab in Extensive-Stage Small Cell Lung Cancer: A Multicenter Prospective Cohort Study
- Choi, Myeong Geun ;
- Kim, Yeon Joo ;
- Lee, Jae Cheol ;
- Ji, Wonjun ;
- Oh, In -Jae ;
- ... Lee, Sung Yong ;
- 외 5명
- 2024-02
- Cancer Research and Treatment
- KOREAN CANCER ASSOCIATION
2023
Article
Final Report on Real-World Effectiveness of Sequential Afatinib and Osimertinib in EGFR-Positive Advanced Non-Small Cell Lung Cancer: Updated Analysis of the RESET Study
- Kim, Taeyun ;
- Jang, Tae Won ;
- Choi, Chang Min ;
- Kim, Mi-Hyun ;
- Lee, Sung Yong ;
- 외 12명
- 2023-10
- Cancer Research and Treatment
- KOREAN CANCER ASSOCIATION
Article
Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY Trial
- Park, Cheol-Kyu ;
- Jun, Ha Ra ;
- Oh, Hyung-Joo ;
- Lee, Ji-Young ;
- Cho, Hyun-Ju ;
- ... Lee, Sung Yong ;
- 외 8명
- 2023-04-25
- Cells
- MDPI
Article
Real-World Study of Osimertinib in Korean Patients with Epidermal Growth Factor Receptor T790M Mutation–Positive Non–Small Cell Lung Cancer
- 이장호 ;
- 김은영 ;
- 박철규 ;
- 이신엽 ;
- 이민기 ;
- ... 이승룡 ;
- 외 16명
- 2023-01-01
- Cancer Research and Treatment
- 대한암학회
Article
NEPTUNE: Phase 3 Study of First-Line Durvalumab Plus Tremelimumab in Patients With Metastatic NSCLC
- de Castro Jr, Gilberto ;
- Rizvi, Naiyer A. ;
- Schmid, Peter ;
- Syrigos, Konstantinos ;
- Martin, Claudio ;
- ... Lee, Sung Yong ;
- 외 17명
- 2023-01-01
- Journal of Thoracic Oncology
- ELSEVIER SCIENCE INC
Article
A real-world study of second or later-line osimertinib in patients with EGFR T790M-positive NSCLC: the final ASTRIS data
- Cheema, Parneet ;
- Cho, Byoung Chul ;
- Freitas, Helano ;
- Provencio, Mariano ;
- Chen, Yuh Min ;
- ... Lee, Sung Yong ;
- 외 20명
- 2023-01
- Future Oncology
- FUTURE MEDICINE LTD
2022
Article
A phase II, multicenter study of lazertinib as consolidation therapy in patients with locally advanced, unresectable, EGFR mutation-positive non-small cell lung cancer (stage III) who have not progressed following definitive, platinum-based, chemoradiation therapy (PLATINUM trial)
- Choi, Juwhan ;
- Lee, Jeong Eun ;
- Choi, Chang-Min ;
- Oh, In-Jae ;
- Lee, Kye Young ;
- ... Lee, Sung Yong ;
- 외 5명
- 2022-12
- Thoracic Cancer
- WILEY
1